# US 2015/0147774 A1 · Expression construct for yeast and a method of using the construct

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147774 A1
- Document ID: US20150147774A1
- Status: Published application
- Kind: A1
- Application number: 14/551,956
- Filed: 2014-11-24
- Published: 2015-05-28
- Earliest claimed: 2013-11-22
- Assignees: National University of Singapore
- Applicants: National University of Singapore
- Inventors: Jifeng YUAN; Chi Bun CHING
- Web page: https://patentgrep.com/patent/US20150147774A1

## CPC

- C12N 15/905: {in yeast}
- C12N 15/81: for yeasts
- C12N 2800/30: Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present disclosure provides an isolated linear expression cassette. The disclosed cassette comprises a bidirectional promoter; a first gene and a second gene that the genes are respectively and operably linked to one end of the bidirectional promoter; a terminator located immediately next to end of each gene; a 5′-homogolgous region to genomic context of interest and a 3′-homogolgous region to genomic context of interest respectively flanking 5′ end and 3′ end of the cassette; and a dominant selection marker residing within the construct and being arranged in between the flanking 5′-homogolgous region to genomic context of interest and a 3′-homogolgous region to genomic context of interest. Preferably, the cassette is capable of being integrated into genome of transformed yeasts upon being transported into the transformed cell.

## Claims

### Claim 1

An isolated linear expression cassette comprising:
a bidirectional promoter;
a first gene and a second gene that the genes are respectively and operably linked to one end of the bidirectional promoter;
a terminator located immediately next to end of each gene;
a 5′-Ty element and a 3′-Ty element respectively flanking 5′ end and 3′ end of the cassette; and
a dominant selection marker residing within the construct and being arranged in between the flanking 5′-Ty element and the 3′-element, wherein the cassette is capable of being integrated into genome of a transformed yeast through the Ty-elements upon being transported into the transformed cell.

### Claim 2 (depends on 1)

The expression cassette of claim 1, wherein the dominant selection marker is an antibiotic selection marker, ble, kanMX, natMX, or hphMX.

### Claim 3 (depends on 1)

The expression cassette of claim 1, wherein the dominant selection marker is coupled to and sandwiched in between a pair of site-specific recombination sequences.

### Claim 4 (depends on 3)

The expression cassette of claim 3, wherein the pair of site-specific recombination sequences are loxP sites recognizable and capable of reacting with Cre recombinase or other equivalents to carry out recombinase-mediated marker recovery.

### Claim 5 (depends on 1)

The expression cassette of claim 1, wherein the bidirectional promoter is formed by any two of the promoters derived from any functional promoter of native yeast cells, other organisms or synthetic promoters.

### Claim 6 (depends on 1)

The expression cassette of claim 1, wherein the first gene and second gene are different.

### Claim 7 (depends on 1)

The expression cassette of claim 1, wherein the first gene and second gene are ID11, tHMG1, ERG 8, ERG10, ERG12, ERG13, ERG19, ERG 20 ILV2, ILV5, ILV3, ARO10 and ADH7.

### Claim 8 (depends on 1)

The expression cassette of claim 1, further comprising a sequence encoding mitochondrial targeting signal peptide.

### Claim 9

A method of transforming yeasts by way of genome integration comprising:
transporting a plurality of linear expression cassettes into yeasts to produce transformed yeasts with at least one copy of the cassette integrated into genome of the yeasts, wherein each of the plurality of linear expression cassettes comprises:
a bidirectional promoter;
a first gene and a second gene that are each operably linked to a corresponding end of the bidirectional promoter;
a terminator located immediately next to the end of each gene;
a 5′-Ty element and a 3′-Ty element respectively flanking 5′ end and 3′ end of the cassette to enable integration of the cassette into genome of the transformed yeast upon transporting the cassette into the yeasts; and
a dominant selection marker residing within the construct and being arranged in between the flanking 5′-Ty element and the 3′-element;
growing the yeast with a medium containing a reagent capable of reacting with a marker expressed from the dominant selection marker by the transformed yeasts to generate a signal thereof; and
identifying the transformed yeasts based upon the generated signal.

### Claim 10 (depends on 9)

The method of claim 9, wherein the marker is against an antibiotic being toxic to the yeasts and the reagent is the antibiotic that the identifying step comprises selecting the transformed yeast with a minimal number of expression cassette integrated based upon resistance capacity of the transformed yeasts against the antibiotic of a predetermined concentration by growing the transformed yeast in the presence of the antibiotic of the predetermined concentration, wherein the resistance capacity of the transformed yeast is substantially in positive correlation with the number of expression cassette integrated into the genome of the transformed yeasts.

### Claim 11 (depends on 9)

The method of claim 9, wherein the first gene and the second gene of one linear expression cassette are different from another linear expression cassette.

### Claim 12 (depends on 9)

The method of claim 9, wherein dominant selection marker is an antibiotic selection marker, ble, kanMX, natMX or hphMX.

### Claim 13 (depends on 9)

The method of claim 9, wherein the dominant selection marker is coupled to and sandwiched in between a pair of site-specific recombination sequences.

### Claim 14 (depends on 13)

The method of claim 13, wherein the pair of site-specific recombination sequences are loxP sites recognizable and capable of reacting with Cre recombinase or other equivalents to carry out recombinase-mediated marker recovery.

### Claim 15 (depends on 9)

The method of claim 9, wherein the first gene and second gene are different and selected from the group consisting of ID11, tHMG1, ERG 8, ERG10, ERG12, ERG13, ERG19, ERG 20 ILV2, ILV5, ILV3, ARO10 and ADH7.

### Claim 16

A method of transforming yeast by way of genome integration comprising:
transporting a plurality of linear expression cassettes into yeasts to produce transformed yeasts with at least one copy of the cassette integrated into the genome, each of the plurality of linear expression cassettes having a dominant selection marker against an antibiotic; and
selecting the transformed yeast with a minimal number of expression cassette integrated based upon resistance capacity of the transformed yeasts against the antibiotic of a predetermined concentration by growing the transformed yeast in the presence of the antibiotic of the predetermined concentration, wherein the resistance capacity of the transformed yeast is substantially in positive correlation with the number of expression cassette integrated into the genome of the transformed yeasts.

### Claim 17 (depends on 16)

The method of claim 16, wherein the antibiotic against by the selection marker is phleomycin and the predetermined concentration is at least 40 μg/mL.

### Claim 18 (depends on 16)

The method of claim 16, wherein the selection marker is ble, kanMX, natMX, hphMX or any modified selection marker derived thereof.
